The Big Picture: PACS vendors vie for piece of software pie

Article

The Big Picture: PACS vendors vie for piece of software pieBy Kathy Kincade, EditorAs the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development

The Big Picture:
PACS vendors vie for piece of software pie

By Kathy Kincade, Editor

As the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development environments tailored to the needs of the medical community. Or is there?

With the increasing sophistication of PACS, certain components are becoming commodities. As a result, some vendors have begun searching for new revenue streams. And with the advent of enterprise-wide image distribution, software represents one potentially lucrative niche. This opportunity has drawn the attention of several PACS and modality vendors, which have created software platforms with the hope of attracting new business from both their customers and their competitors.

But is this just another example of trying to reinvent the wheel? A handful of software developers have been adequately serving this market for many years. In addition, the medical imaging community has been quite successful in its cooperative approach to standards development. Look at DICOM and HL7.

And then there is the open architecture of the PC itself, which overcomes the legacy-system problem and offers a number of non-healthcare-specific application-development tools created and refined by computer companies with immense resources and expertise at their disposal. Software is, after all, their business.

But not necessarily software that is specific to the needs of the medical imaging industry. That requires yet another level of expertise from developers who understand how the medical community works and what tools they need to help them do their jobs better.

© 2000 Miller Freeman, Inc., a United News & Media company

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.